MR Contrast Selection & Utilization in Pediatric & Neonatal Patients

Viewing Information

Getting Started

Read all the information presented below. When ready select the "View Program" tab above.

Claiming CME/CE Credits

To receive credits, participants must review the program materials in their entirety and complete the online post examination and evaluation. CME credits require a post examination score of 70% or higher. CE credits require a post examination score of 80% or higher.

Effective Date: November 22, 2021
CME/CE Expiration Date: December 31, 2026
Format: Self Instructional - Audio Visual with Slides
Educational Credits:
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour

Commercial Support

Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.

Target Audience & Cost

This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.

There is no cost to participate in this program.

Program Summary

In MR Imaging, a careful review of the safety criteria for the selection of a Gadolinium-based Contrast Agents (GBCAs) should be considered for pediatric and neonatal patients. The program will provide a comprehensive review of the supporting research that addresses Gadolinium selection in this special patient population. Both chronic and long-term effects of GBCAs will be discussed.

As a Pediatric Neuroradiologist, Dr. Shah is uniquely qualified to share his experience which includes a discussion of risk vs benefits, supported by practical protocols for the administration of MR contrast; including limiting the amount of contrast given to patients that may receive several lifetime doses.

Following the presentation questions from the audience were addressed in a moderated Q&A session.

Educational Objectives

At the completion of this activity, participants should be able to:

  • Explain the differences between available MR contrast agents and any associated adverse events
  • Improve clinical management decisions about when to administer MR contrast (risk vs benefit)
  • Apply FDA guidelines regarding MRI contrast agents to clinical practice.

No special educational preparation is required for this CME/CE activity!


Chetan C. Shah, MBBS

Chetan C. Shah, MBBS

Chair of Radiology
Nemours Wolfson Children's Hospital

Dr. Chetan C. Shah is a board certified radiologist in Jacksonville, Florida and is affiliated withNemours Children's Hospital. He received his medical degree from Topiwala National Medical College and has been in practice for more than 20 years.

Conflict of Interest Disclosure Policy

Applied Radiology requires everyone who is in a position to control the content of a CE activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE activity.


Chetan C. Shah, MBB discloses the following:No personal financial conflict. Nemours received Research grant from Bracco Diagnostics Inc. and Principal Investigator in the research on Gadoteridol

No individual at IAME who had control over the content of this program has relationships with Bracco Diagnostics, Inc. or any other commercial supporter.


The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.

Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Operations Management and Asset Management.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.

Method of Participation/Criteria for Success

CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.

CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.

Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.